Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies
Phase 1
Completed
- Conditions
- Advanced Nonhaematologic Malignancies
- Interventions
- First Posted Date
- 2017-11-01
- Last Posted Date
- 2021-04-15
- Lead Sponsor
- Boston Pharmaceuticals
- Target Recruit Count
- 38
- Registration Number
- NCT03328494
- Locations
- π¬π§
Edinburgh Cancer Centre - Western General Hospital, Edinburgh, United Kingdom
π¬π§Addenbrooks Hospital, Cambridge, United Kingdom
π¬π§Royal Marsden, London, United Kingdom
Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of BOS161721 in Healthy Subjects
- First Posted Date
- 2017-01-30
- Last Posted Date
- 2020-11-18
- Lead Sponsor
- Boston Pharmaceuticals
- Target Recruit Count
- 61
- Registration Number
- NCT03036865
Β© Copyright 2025. All Rights Reserved by MedPath